AU2002327097A1 - Novel glycolipid and remedial agent for autoimmune disease containing the same as active ingredient - Google Patents

Novel glycolipid and remedial agent for autoimmune disease containing the same as active ingredient

Info

Publication number: AU2002327097A1
Authority: AU; Australia
Prior art keywords: active ingredient; same; autoimmune disease; disease containing; remedial agent
Prior art date: 2001-08-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002327097A

Other versions

AU2002327097B2 (en

Inventor

Sachiko Miyake

Takashi Yamamura

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Japan As Represented By President Of National Centre Of Neurology And Psychiatry

Original Assignee

Japan As Represented By President Of National Centre Of Neurology And Psychiatry

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-16

Filing date

2002-08-14

Publication date

2003-05-29

2002-08-14 Application filed by Japan As Represented By President Of National Centre Of Neurology And Psychiatry filed Critical Japan As Represented By President Of National Centre Of Neurology And Psychiatry

2002-08-14 Priority claimed from PCT/JP2002/008280 external-priority patent/WO2003016326A1/en

2003-05-29 Publication of AU2002327097A1 publication Critical patent/AU2002327097A1/en

2005-11-03 Assigned to DAIICHI ASUBIO PHARMA CO., LTD., JAPAN AS REPRESENTED BY PRESIDENT OF NATIONAL CENTRE OF NEUROLOGY AND PSYCHIATRY reassignment DAIICHI ASUBIO PHARMA CO., LTD. Amend patent request/document other than specification (104) Assignors: DAIICHI SUNTORY PHARMA CO., LTD., JAPAN AS REPRESENTED BY PRESIDENT OF NATIONAL CENTRE OF NEUROLOGY AND PSYCHIATRY

2007-05-24 Application granted granted Critical

2007-05-24 Publication of AU2002327097B2 publication Critical patent/AU2002327097B2/en

2007-06-21 Assigned to JAPAN AS REPRESENTED BY PRESIDENT OF NATIONAL CENTRE OF NEUROLOGY AND PSYCHIATRY, ASUBIO PHARMA CO., LTD. reassignment JAPAN AS REPRESENTED BY PRESIDENT OF NATIONAL CENTRE OF NEUROLOGY AND PSYCHIATRY Request for Assignment Assignors: DAIICHI ASUBIO PHARMA CO., LTD., JAPAN AS REPRESENTED BY PRESIDENT OF NATIONAL CENTRE OF NEUROLOGY AND PSYCHIATRY

2010-04-29 Assigned to JAPAN AS REPRESENTED BY PRESIDENT OF NATIONAL CENTRE OF NEUROLOGY AND PSYCHIATRY reassignment JAPAN AS REPRESENTED BY PRESIDENT OF NATIONAL CENTRE OF NEUROLOGY AND PSYCHIATRY Request for Assignment Assignors: ASUBIO PHARMA CO., LTD., JAPAN AS REPRESENTED BY PRESIDENT OF NATIONAL CENTRE OF NEUROLOGY AND PSYCHIATRY

2022-08-14 Anticipated expiration legal-status Critical

Status Expired legal-status Critical Current

Links

AU2002327097A 2001-08-16 2002-08-14 Novel glycolipid and remedial agent for autoimmune disease containing the same as active ingredient Expired AU2002327097B2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2001-247055		2001-08-16
JP2001247055		2001-08-16
PCT/JP2002/008280 WO2003016326A1 (en)	2001-08-16	2002-08-14	Novel glycolipid and remedial agent for autoimmune disease containing the same as active ingredient

Publications (2)

Publication Number	Publication Date
AU2002327097A1 true AU2002327097A1 (en)	2003-05-29
AU2002327097B2 AU2002327097B2 (en)	2007-05-24

Family

ID=19076468

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002327097A Expired AU2002327097B2 (en)	2001-08-16	2002-08-14	Novel glycolipid and remedial agent for autoimmune disease containing the same as active ingredient

Country Status (15)

Country	Link
US (1)	US8367623B2 (en)
EP (1)	EP1437358B1 (en)
JP (1)	JP4064346B2 (en)
KR (1)	KR100880063B1 (en)
CN (1)	CN100439383C (en)
AT (1)	ATE342910T1 (en)
AU (1)	AU2002327097B2 (en)
BR (1)	BR0211968A (en)
CA (1)	CA2459482C (en)
DE (1)	DE60215530T2 (en)
DK (1)	DK1437358T3 (en)
ES (1)	ES2274080T3 (en)
HU (1)	HU229345B1 (en)
NO (1)	NO326398B1 (en)
WO (1)	WO2003016326A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9809654B2 (en)	2002-09-27	2017-11-07	Vaccinex, Inc.	Targeted CD1d molecules
CA2515396A1 (en)	2003-02-14	2004-08-26	Daiichi Suntory Pharma Co., Ltd.	New glycolipids and synthetic method thereof as well as their synthetic intermediates,and synthetic method thereof
KR101377116B1 (en) *	2004-08-27	2014-03-24	알버트 아인슈타인 컬리지 오브 메디신 오브 예쉬바 유니버시티	Ceramide derivatives as modulators of immunity and autoimmunity
ES2861199T3 (en)	2004-10-07	2021-10-06	Argos Therapeutics Inc	Mature Dendritic Cell Compositions and Procedures for Culturing Them
US8513008B2 (en)	2004-10-07	2013-08-20	Argos Therapeutics, Inc.	Mature dendritic cell compositions and methods for culturing same
US7534434B2 (en) *	2004-12-28	2009-05-19	The Rockefeller University	Glycolipids and analogues thereof as antigens for NK T cells
US7923013B2 (en)	2004-12-28	2011-04-12	The Rockefeller University	Glycolipids and analogues thereof as antigens for NKT cells
US20090214596A1 (en) *	2005-04-01	2009-08-27	Riken	Nasal Vaccine
CA2613350A1 (en) *	2005-07-01	2007-01-11	Japan As Represented By President Of National Center Of Neurology And Ps Ychiatry	Glycolipid derivative and drug containing the same as active component
KR20080059611A (en) *	2005-10-28	2008-06-30	국립 정신.신경센터 총장이 대표하는 일본국	Therapeutic Agents Using Glycolipid Derivatives That Inhibit NNT Cell Function
US8163705B2 (en)	2006-02-28	2012-04-24	Riken	Glycolipid and use thereof
US7794722B2 (en)	2006-06-30	2010-09-14	The Scripps Research Institute	Adjuvants and methods of use
KR100868959B1 (en) *	2006-12-30	2008-11-17	재단법인서울대학교산학협력재단	Alpha-galactosyl ceramide derivatives, pharmaceutically acceptable salts thereof, preparation methods thereof, and immunosuppressive pharmaceutical compositions containing the same as active ingredients
CA2678618C (en)	2007-02-21	2019-03-12	Vaccinex, Inc.	Modulation of nkt cell activity with antigen-loaded cd1d molecules
ES2574825T3 (en)	2007-10-12	2016-06-22	Luigi Panza	Glycolipid analogs useful as immunoadjuvants
NZ593794A (en) *	2009-01-08	2013-04-26	Einstein Coll Med	Bacterial vaccines with cell wall-associated ceramide-like glycolipids and uses thereof
US9371352B2 (en)	2013-02-08	2016-06-21	Vaccinex, Inc.	Modified glycolipids and methods of making and using the same
JP6202339B2 (en) *	2013-12-19	2017-09-27	国立研究開発法人国立精神・神経医療研究センター	GM-CSF producing T cell regulator and Th1 / Th2 immune balance regulator
EP3111945B1 (en)	2014-02-26	2021-07-14	National University Corporation Hokkaido University	Dendritic cells for use in the treatment of myocardial infarction
EP3984597A4 (en)	2019-07-12	2023-07-12	Kyushu University, National University Corporation	DEVELOPMENT OF A THERAPY TO IMPROVE MYOCARDIAL CONTRACTION AND A METHOD OF INHIBITION OF CARDIOMYOCYTE DEATH
MX2023010240A (en)	2021-03-01	2023-11-24	Deciduous Therapeutics Inc	COMPOUNDS TO ACTIVATE INVARIANT NATURAL KILLER T CELLS AND METHODS OF USE IN THE ELIMINATION OF INFLAMMATORY SENESCENT CELLS.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5827828A (en) *	1981-08-11	1983-02-18	Mitsubishi Electric Corp	Fuel injection device
DK84691D0 (en)	1991-05-07	1991-05-07	Karsten Buschard	CERTAIN GLYCOLIPIDES AND SPECIFIC CATCHERS FOR USE IN PROPHYLAXES OR THERAPY THERAPY AND / OR CONSEQUENTIAL COMPLICATIONS AND THE APPLICATION OF SUCH ANIMALS OF ANY CELLIPOLS TO DETECT OE CELEBRATES -EU CELLS IN PANCREAS PREPARATIONS
US5936076A (en) *	1991-08-29	1999-08-10	Kirin Beer Kabushiki Kaisha	αgalactosylceramide derivatives
JPH0559081A (en) *	1991-08-29	1993-03-09	Kirin Brewery Co Ltd	New sphingoglycolipid, its production and use
GB9207182D0 (en) *	1992-04-01	1992-05-13	Enzymatix Ltd	Glycolipids and their preparation
TW261533B (en) *	1992-07-16	1995-11-01	Kirin Brewery
CA2142153A1 (en) *	1994-03-04	1995-09-05	Jacques Banville	Sulfated .beta.-glycolipid derivatives as cell adhesion inhibitors
CN1058498C (en) *	1994-05-31	2000-11-15	生化学工业株式会社	Glycolipid analogs
DE19602108A1 (en) *	1996-01-22	1997-07-24	Beiersdorf Ag	Substances effective against bacteria, parasites, protozoa, mycota and viruses
JP4451933B2 (en) *	1996-12-27	2010-04-14	住友化学株式会社	Method of imparting PPO-inhibiting herbicide tolerance to plants by genetic manipulation
KR100527950B1 (en) *	1997-04-10	2005-11-09	기린 비루 가부시키가이샤	NKT CELL ACTIVATORS CONTAINING α-GLYCOSYLCERAMIDES
US6589940B1 (en) *	1997-06-06	2003-07-08	Dynavax Technologies Corporation	Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
TW575420B (en) *	1997-09-22	2004-02-11	Kirin Brewery	Composition for enhancing cellular immunogenicity comprising alpha-glycosylceramides
US7273711B1 (en) *	1998-12-02	2007-09-25	The Regents Of The University Of California	Diagnosis of human glycosylation disorders
JP2002284692A (en) *	2001-03-26	2002-10-03	Kirin Brewery Co Ltd	SUPPRESSION OF GRAFT-VERSUS-HOST DISEASE(GVHD) BY alpha- GLYCOSYLCERAMIDE

2002
- 2002-08-14 ES ES02760637T patent/ES2274080T3/en not_active Expired - Lifetime
- 2002-08-14 DE DE60215530T patent/DE60215530T2/en not_active Expired - Lifetime
- 2002-08-14 AU AU2002327097A patent/AU2002327097B2/en not_active Expired
- 2002-08-14 JP JP2003521248A patent/JP4064346B2/en not_active Expired - Lifetime
- 2002-08-14 CN CNB028203615A patent/CN100439383C/en not_active Expired - Lifetime
- 2002-08-14 US US10/486,948 patent/US8367623B2/en not_active Expired - Fee Related
- 2002-08-14 DK DK02760637T patent/DK1437358T3/en active
- 2002-08-14 WO PCT/JP2002/008280 patent/WO2003016326A1/en active IP Right Grant
- 2002-08-14 KR KR1020047002291A patent/KR100880063B1/en not_active Expired - Lifetime
- 2002-08-14 CA CA2459482A patent/CA2459482C/en not_active Expired - Lifetime
- 2002-08-14 EP EP02760637A patent/EP1437358B1/en not_active Expired - Lifetime
- 2002-08-14 AT AT02760637T patent/ATE342910T1/en not_active IP Right Cessation
- 2002-08-14 HU HU0500127A patent/HU229345B1/en unknown
- 2002-08-14 BR BR0211968-4A patent/BR0211968A/en not_active IP Right Cessation
2004
- 2004-02-13 NO NO20040653A patent/NO326398B1/en not_active IP Right Cessation

Publication	Publication Date	Title
AU2002327097A1 (en)	2003-05-29	Novel glycolipid and remedial agent for autoimmune disease containing the same as active ingredient
HUP0500127A3 (en)	2009-12-28	Novel glycolipid and remedial agent for autoimmune disease containing the same as active ingredient
IL157741A0 (en)	2004-03-28	Pharmaceutical compositions containing an antihyperplastic active agent
AU2000279625A1 (en)	2002-05-15	Blood mmp-3 level-lowering agent containing il-6 antgonist as the active ingredient
AU3243300A (en)	2000-09-14	Multiparticulate formulation
AU2001295657A1 (en)	2002-04-22	Formulation containing wax-esters
AU2002258559A1 (en)	2002-10-08	Skin care compositions
AU2002257582A1 (en)	2002-09-04	Pharmaceutical formulation
AU4328800A (en)	2000-11-10	Pharmaceutical formulation
AU2002302544A1 (en)	2003-04-17	Active ingredient combinations for hair-dyeing agents
AU2001248215A1 (en)	2001-11-26	Cosmetically active composition
AU6386801A (en)	2001-11-12	System for the release of active ingredients
AU2001232866A1 (en)	2001-07-31	Skin care compositions
AU1554301A (en)	2001-06-12	Radioprotecting agent
EP1011689B8 (en)	2007-05-09	USE OF 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
AU3839900A (en)	2000-11-10	Pharmaceutical formulation
AU5182099A (en)	2000-03-06	Pharmaceutical formulation
GB0029650D0 (en)	2001-01-17	Proces for the preparation of 1,1-cyclopropanedicarboxylic diesters
AU2001262148A1 (en)	2001-10-15	Use of 3-iodine-2-propinyl-carbamates as antimicrobial active agent
AU2002340440A1 (en)	2003-06-10	Foamable antimicrobial formulation
AU2001275696A1 (en)	2002-02-05	Therapeutic agent
AU1388501A (en)	2001-06-06	Pharmaceutical formulation
AU1345500A (en)	2001-06-06	Disinfecting agent
AU3175500A (en)	2000-10-04	Insecticide formulation
AU2002249233A1 (en)	2002-09-24	Cosmetic or pharmaceutical agent